Technical Analysis for TVTX - Travere Therapeutics, Inc.

Grade Last Price % Change Price Change
F 5.45 -5.05% -0.29
TVTX closed down 5.05 percent on Wednesday, April 24, 2024, on 2.21 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 2
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -5.05%
Oversold Stochastic Weakness -5.05%
NR7 Range Contraction -6.84%
Wide Bands Range Expansion -6.84%
Oversold Stochastic Weakness -6.84%
Doji - Bullish? Reversal -4.72%
Wide Bands Range Expansion -4.72%
Down 3 Days in a Row Weakness -4.72%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 12 hours ago
Down 5% about 14 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Down 3% about 15 hours ago
Down 2 % about 16 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis

Is TVTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.75
52 Week Low 5.25
Average Volume 1,254,102
200-Day Moving Average 9.51
50-Day Moving Average 7.41
20-Day Moving Average 6.56
10-Day Moving Average 6.01
Average True Range 0.39
RSI (14) 23.66
ADX 39.04
+DI 7.78
-DI 36.33
Chandelier Exit (Long, 3 ATRs) 6.96
Chandelier Exit (Short, 3 ATRs) 6.50
Upper Bollinger Bands 7.86
Lower Bollinger Band 5.26
Percent B (%b) 0.07
BandWidth 39.64
MACD Line -0.55
MACD Signal Line -0.47
MACD Histogram -0.0756
Fundamentals Value
Market Cap 409.54 Million
Num Shares 75.1 Million
EPS -4.42
Price-to-Earnings (P/E) Ratio -1.23
Price-to-Sales 2.82
Price-to-Book 2.23
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.11
Resistance 3 (R3) 6.15 5.96 6.00
Resistance 2 (R2) 5.96 5.80 5.95 5.96
Resistance 1 (R1) 5.71 5.69 5.62 5.67 5.93
Pivot Point 5.52 5.52 5.48 5.51 5.52
Support 1 (S1) 5.27 5.36 5.18 5.23 4.97
Support 2 (S2) 5.08 5.25 5.07 4.94
Support 3 (S3) 4.83 5.08 4.90
Support 4 (S4) 4.79